Total Estrogen Test · Blood

Your body does not make just one estrogen. It makes three: estradiol, estrone, and estriol. Each plays different roles at different stages of life, and a total estrogen test adds them together to give you a single number that reflects the combined hormonal signal reaching your bones, heart, brain, and reproductive organs. That composite number tells you something no individual estrogen test can: whether your overall estrogen exposure is in a range that supports health or one that raises risk.

This matters because estrogen is not simply "good" or "bad." Too little accelerates bone loss and raises cardiovascular risk. Too much, especially after menopause, is one of the strongest known drivers of hormone-driven breast cancer, the type whose growth is fueled by estrogen. Knowing your total estrogen helps you and your clinician understand which side of that balance you are on, and whether your interventions (weight loss, exercise, hormone therapy) are actually shifting it.

What Total Estrogen Actually Measures

Total estrogen is the sum of three steroid hormones, all built from cholesterol. Estradiol (E2) is the most potent and dominates during your reproductive years. Estrone (E1) becomes the main circulating estrogen after menopause, produced largely in fat tissue. Estriol (E3) is mostly relevant during pregnancy. When a lab reports "total estrogen," it is adding the concentrations of these molecules together from a single blood draw, reported in picograms per milliliter (pg/mL).

A key enzyme called aromatase converts androgens (like testosterone and androstenedione) into estrogens. Your ovaries are the primary factory before menopause. After menopause, aromatase in fat tissue, breast tissue, bone, and brain takes over. This is why body composition has such a powerful influence on your total estrogen level, and why weight loss is one of the most reliable ways to lower it.

The gut also plays a surprising role. Bacteria in your intestines produce enzymes that reactivate estrogens that were deactivated by your liver and excreted into bile. A study of 51 men and postmenopausal women found that greater diversity of gut bacteria, particularly certain species of Clostridia, correlated strongly with higher systemic estrogen levels. This recycling loop means your microbiome is quietly shaping your estrogen exposure every day.

Breast Cancer Risk

The link between estrogen and breast cancer risk is one of the most extensively studied relationships in cancer biology. In postmenopausal women, higher circulating estradiol and estrone levels are associated with a significantly increased risk of hormone receptor positive breast cancer (the type whose growth is fueled by hormones like estrogen). A collaborative reanalysis pooling individual data from seven prospective studies of premenopausal women confirmed that higher circulating estrogens and androgens are positively associated with breast cancer risk even before menopause.

In a prospective study of over 14,000 postmenopausal women followed for up to a decade, those with the highest levels of estrone and estradiol at baseline had a meaningfully elevated risk of developing breast cancer later, even when their levels were within the "normal" postmenopausal range. Lower binding of estradiol to SHBG (sex hormone binding globulin, a protein that carries estrogen in the blood and keeps it inactive) further increased that risk.

If your total estrogen is elevated for your age and menopausal status, that does not mean you have cancer. It means your tissue exposure to estrogen is higher than average, and that information should inform your screening decisions, lifestyle choices, and conversations about risk reduction.

Cardiovascular and Stroke Risk

Estrogen is broadly protective for blood vessels during the reproductive years. It promotes blood vessel relaxation, supports healthy blood vessel lining, and modulates inflammation. The flip side is that losing estrogen exposure earlier in life raises risk. A meta-analysis of 17 studies found that women with a shorter reproductive lifespan (the gap between first menstrual period and menopause) had about 31% higher risk of stroke compared to those with longer estrogen exposure.

In men, very low estradiol also carries risk. An individual participant meta-analysis drawing on data from nine cohorts and over 255,000 person years of follow-up found that men with extremely low estradiol concentrations (below about 5 picomoles per liter) had higher all-cause and cardiovascular mortality, independent of testosterone levels and traditional risk factors.

For both sexes, the message is that estrogen at the right level is protective. This test helps you see whether your level falls in that protective range, especially if you are in a transition period such as perimenopause (the years leading up to menopause) or post-surgical menopause, where levels may drop faster than expected.

Bone Health

Estrogen is one of the primary regulators of bone turnover in both women and men. It suppresses the cells that break down bone (osteoclasts) and supports the cells that build it (osteoblasts). When estrogen falls, bone breakdown accelerates and new bone formation cannot keep pace. This is the central mechanism behind postmenopausal osteoporosis, the most common form of bone loss in women.

If your total estrogen is consistently low and you have other risk factors for bone loss (family history, low body weight, smoking, sedentary lifestyle), a bone density scan and a conversation with an endocrinologist about whether hormone replacement might be appropriate are reasonable next steps.

Metabolism and Body Composition

Estrogens influence where your body stores fat, how sensitive your cells are to insulin, and how many calories you burn at rest. A systematic review found that estrogen administration increases resting energy expenditure, which may help explain why weight gain is so common after menopause when estrogen drops. Estrogen deficiency also promotes a shift toward abdominal fat storage, insulin resistance, and unhealthy cholesterol and fat levels in the blood, all of which compound cardiovascular risk.

The relationship runs both directions. Higher body fat means more aromatase activity, which means more estrogen production. In a study of over 4,000 postmenopausal women in the MAP.3 breast cancer prevention trial, BMI was the single largest factor affecting baseline estrogen levels, though it still explained only about 20% of the variation. This means your weight matters, but it is not the whole story.

Ethnic Differences in Estrogen Levels

Your ethnicity can meaningfully shift your baseline. In the Multiethnic Cohort study of 739 postmenopausal women, Native Hawaiian women had the highest estrone and estradiol levels, with estradiol running about 26% higher than in white women after adjusting for age, BMI, and other risk factors. African American women were about 20% higher, and Japanese American women about 15% higher. Latina women had levels similar to white women. These differences track with known differences in postmenopausal breast cancer incidence across these groups.

The SWAN study, which followed 3,257 women of multiple ethnicities through the menopausal transition, added another layer: Chinese and Japanese women had lower estradiol than white women during the transition, while African American women had higher FSH (follicle stimulating hormone, the pituitary signal that drives ovarian estrogen production) but similar estradiol. These patterns mean that a "normal" total estrogen for one ethnic group may not be normal for another, and your results should be interpreted with your background in mind.

Reference Ranges

Total estrogen reference ranges depend heavily on your sex, age, menopausal status, and the assay your lab uses. Modern mass spectrometry (LC-MS/MS) is now the gold standard, especially at the low postmenopausal levels where older immunoassays (like RIA or ELISA) tend to overestimate. A comparison study of 488 urine samples found LC-MS/MS significantly more reliable than older methods, particularly in postmenopausal women where estrogen concentrations are very low.

These ranges come from a large Danish LC-MS/MS study of 1,838 healthy people from infancy through age 61, plus pooled postmenopausal data. They are approximate orientation, not universal targets. Your lab may report different numbers, and the specific assay method matters greatly at low concentrations.

For postmenopausal women specifically, a dedicated review of LC-MS/MS and GC-MS data proposed an updated normal estradiol range of undetectable to 10.7 pg/mL, with a mean around 3.9 pg/mL. Earlier immunoassay based "normal" values of 20 to 30 pg/mL are likely overestimates and should be interpreted cautiously. If your lab uses an older assay method, your results may look higher than the mass spectrometry values above.

Always compare your results within the same lab and same assay method over time. A number from one lab using immunoassay is not directly comparable to a number from another lab using mass spectrometry.

When Results Can Be Misleading

The within-person variability for estradiol over a single day is about 13%, meaning your result could swing by that much depending on when during the day your blood was drawn. Morning values tend to run about 2% higher than the daily average. This variability is moderate compared to some hormones (like LH, which bounces much more), but it is enough to matter if your result is borderline.

• Body weight changes: Gaining or losing significant weight shifts estrogen production from fat tissue. A result drawn during active weight loss may not represent your stable baseline.
• Menstrual cycle timing: In premenopausal women, estrogen can vary five-fold across the cycle. A single draw without knowing your cycle day is nearly uninterpretable.
• Assay method: Immunoassays (RIA, ELISA) can overestimate estrogen by cross-reacting with other molecules, especially at low postmenopausal levels. If your result seems unexpectedly high, ask whether your lab used mass spectrometry.
• BMI and feeding state: Higher BMI raises baseline estrogen. Feeding has a smaller effect on estradiol than on testosterone, but fasting before your draw improves consistency.